MedTrace Logo

Non-interventional (NI) Study to Observe Efficacy and Usage of Quetiapine in Acute Episodes of Schizophrenia and as Maintenance Therapy Following Standard Clinical Practice in Croatia

NCT00981123 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2011-01-10

No results posted yet for this study

Summary

Observational, non-comparative, epidemiological study to collect and analyse real life data on schizophrenic patients receiving quetiapine according to the standard medical practice in Croatia. The main objectives are to assess after 6 months of quetiapine therapy severity of illness and global improvement in patients using Clinical Global Impression (CGI) scale.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Ana Marija Gjurovic, MD, MSc · AstraZeneca Medical Department

  • Andreja Hasenohrl, DVM · AstraZeneca Medical Department

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2010-04-30
Completion
2010-04-30

Countries

  • Croatia

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00981123 on ClinicalTrials.gov